Dual Site-dual Channel Non-invasive Brain Stimulation for Motor Function in Stroke Patients
NCT ID: NCT03486769
Last Updated: 2020-05-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2018-05-23
2020-03-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dual Site-dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Stroke Patients
NCT03486782
The Effect of tDCS on Motor Learning and Neural Network in Stroke Patients
NCT04903457
Most Effective Stimulation Site in Transcranial Direct Current Stimulation for Gait Recovery After Stoke
NCT03460886
The Effect of tDCS Based on Functional Brain Imaging for Subacute Stroke Patients
NCT05142917
A Study on Brain Activity During Transcranial Direct Current Stimulation in Stroke Patients
NCT04549753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dual Stimulation 1
i) anodal stimulation on ipsilesional primary motor cortex and cathodal stimulation on contralesional primary motor cortex, ii) anodal stimulation on ipsilesional premotor cortex and cathodal stimulation on contralesional supraorbital area.
M1 stimulation
stimulating primary motor cortex with anodal transcranial direct current stimulation
PMC stimulation
stimulating premotor cortex with anodal transcranial direct current stimulation
hand motor task
hand motor task for 30 minutes during transcranial direct current stimulation
Dual Stimulation 2
i) anodal stimulation on ipsilesional primary motor cortex and cathodal stimulation on contralesional primary motor cortex, ii) anodal stimulation on ipsilesional anterior intraparietal sulcus and cathodal stimulation on contralesional supraorbital area.
M1 stimulation
stimulating primary motor cortex with anodal transcranial direct current stimulation
aIPS stimulation
stimulating anterior intraparietal sulcus with anodal transcranial direct current stimulation
hand motor task
hand motor task for 30 minutes during transcranial direct current stimulation
Single stimulation
anodal stimulation on ipsilesional primary motor cortex and cathodal stimulation on contralesional primary motor cortex
M1 stimulation
stimulating primary motor cortex with anodal transcranial direct current stimulation
hand motor task
hand motor task for 30 minutes during transcranial direct current stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
M1 stimulation
stimulating primary motor cortex with anodal transcranial direct current stimulation
PMC stimulation
stimulating premotor cortex with anodal transcranial direct current stimulation
aIPS stimulation
stimulating anterior intraparietal sulcus with anodal transcranial direct current stimulation
hand motor task
hand motor task for 30 minutes during transcranial direct current stimulation
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fugl Meyer Assessment score between 9 to 84
Exclusion Criteria
* history of psychiatric disease
19 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-08-124-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.